Abstract
Noninvasive management of the diabetic foot with critical limb ischemia: current options and future perspectives by Mathias Weck, Torsten Slesaczeck, Hannes Rietzsch, Dirk Münch, Thomas Nanning, Hartmut Paetzold Hans-Joachim Florek, Andreas Barthel, Norbert Weiss and Stefan Bornstein. Therapeutic Advances in Endocrinology and Metabolism 2011; 2(6) 247–255, [DOI: 10.1177/2042018811427721]
The authors would like to apologize for the following error on page 4 of the article:
It currently reads:
“Urokinase (1 IU if plasma fibrinogen ≥ 2.5 g/l; 0.5 IU if fibrinogen <2.5 g/l) was administered for 21 days as an intravenous infusion over 30 minutes.”
However, it should read:
“Urokinase (1 Million IU if plasma fibrinogen ≥ 2.5 g/l; 0.5 Million IU if fibrinogen <2.5 g/l) was administered for 21 days as an intravenous infusion over 30 minutes.”